The number of professional scientific and investment bodies that have looked thoroughly at the research and not found the faults some of the posters here have is quite amazing!
Either many posters here have not read or do not understand the research or there is a massive conspiracy between many different well respected organisations throughout the globe.
Besides Uniquest the list of bodies that were impressed with this device :
. Received a Grand Challenges in Global Health Exploration grant from The Bill & Melinda Gates Foundation to develop cough analysis technology targeting pneumonia diagnosis.
. • Received People’s Choice Award for Most Promising Childhood Pneumonia Innovation received at Pneumonia Innovations Summit, New York.
.Awarded ‘Best Tech IPO/Venture Capital Raising’ in the 2016 Talent Unleashed Awards for both the Asia Pacific Division and in the Global Grand Finals. 2016
- Named Australian Emerging Company of the Year – Johnson & Johnson Innovation Industry Excellence Award • Received Innovation Excellence Award at the Tech23 2016 Awards Ceremony.
- Engineers Australia named Associate Professor Abeyratne one of Australia’s Most Innovative Engineers.
- Just Actions (New York) and StopPneumonia.org named Associate Professor Abeyratne one of the 30 Hidden Heroes Fighting a Silent Killer (pneumonia) in the world.
Covered by Morgans Financials in July 2017 with a target price of .48c
Covered by NDF Research in June 2017 with a target price of .85c
Covered by Pattersons in Dec 2016 with a target price of .59c